Cargando…
Delayed allogeneic skin graft rejection in CD26-deficient mice
Organ transplantation is an effective therapeutic tool for treating many terminal diseases. However, one of the biggest challenges of transplantation is determining how to achieve the long-term survival of the allogeneic or xenogeneic transplant by, for example, preventing transplant rejection. In t...
Autores principales: | Zhao, Xiangli, Zhang, Kai, Daniel, Peter, Wisbrun, Natali, Fuchs, Hendrik, Fan, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804736/ https://www.ncbi.nlm.nih.gov/pubmed/29572550 http://dx.doi.org/10.1038/s41423-018-0009-z |
Ejemplares similares
-
Skin graft rejection by beta 2-microglobulin-deficient mice
Publicado: (1992) -
CELL-MEDIATED CYTOTOXICITY DURING REJECTION AND ENHANCEMENT OF ALLOGENEIC SKIN GRAFTS IN RATS
por: Peter, Hans-Hartmut, et al.
Publicado: (1972) -
Involvement of CD26 in Differentiation and Functions of Th1 and Th17 Subpopulations of T Lymphocytes
por: Zhao, Xiangli, et al.
Publicado: (2021) -
A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo
por: Jayarajan, Senthil, et al.
Publicado: (2022) -
Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans
Publicado: (1993)